Shaken MorphoSys ‘Assessing Options’ After Losing US Darzalex Patent Ruling

 
• By Sten Stovall

But German Biotech says court summary judgement will have no bearing on MorphoSys's own CD38 antibody MOR202.

WoodenFigure
MorphoSys Hit By Patent Lawsuit Ruling Over Blood Cancer Drug • Source: Shutterstock

More from Legal & IP

More from Business